While water fluoridation has great benefits for tooth decay prevention, research indicates that in pregnant women, fluoride crosses the placenta and accumulates in brain regions involved in learning and memory.
©LIGHTFIELD STUDIOS - stock.adobe.com
While water fluoridation has great benefits for tooth decay prevention, research indicates that in pregnant women, fluoride crosses the placenta and accumulates in brain regions involved in learning and memory. A new study in JAMA Pediatrics explored how maternal fluoride exposure during pregnancy impacts childhood IQ.
The prospective, multicenter birth cohort study used information from the Maternal-Infant Research on Environmental Chemicals (MIREC) program, which recruited pregnant women from 10 cities across Canada. The sample included mother-child pairs and children were between ages 3 and 4 at the time of testing. Forty-one percent of the participants lived in communities supplied with fluoridated municipal water.
The authors used maternal urinary fluoride (MUFSG), adjusted for specific gravity and averaged across each trimester of pregnancy. Water treatment plants measured fluoride levels daily if fluoride was added to municipal drinking water and weekly or monthly it was not added. Participants’ postal codes were matched with water treatment plant zones to provide an estimate of water fluoride concentration for each woman. Participants also self-reported daily fluoride intake from water and beverage consumption.
Among the 512 mother-child pairs included in the study, mean (SD) age for enrollment for mothers was 32.3 (5.1) years. The majority (90%) of participants were white and 264 children (52%) were female. Data on MUFSG concentrations, IQ scores and complete covariates were available for al mother-child pairs, but self-reported data on maternal fluoride intake and children’s IQ were available for 400 pairs.
Women who lived in areas with fluoridated tap water (n=141) had significantly higher mean MUFSG (SD) concentrations than women in areas with non-fluoridated tap water (n=228) (0.69 [0.42] mg/L vs 0.40 [0.27] mg/L; P =.001, respectively) and fluoride intake levels (0.93 [0.43] vs 0.30 [0.26] mg of fluoride per day; P =.001, respectively).
Children had mean (SD) Full Scale IQ scores of 107.16 (13.26), range 52-143. Girls in the study (109.56 [11.96]) had significantly higher mean (SD) scores than boys (104.61 [14.09). The authors also noted a significant interaction (P = .02) between child sex and MUFSG (6.89; 95% CI 0.96 – 12.82) and they believe this indicated a differential association between boys and girls.
Results from the study indicated that in boys, as maternal fluoride levels increased, IQ levels decreased. Fluoride levels are significantly associated with a lower IQ in boys, but this relationship was not evident in girls. A 1-mg/L increase in MUFSG was associated with a 4.49-point lower IQ score (95% CI -8.38 to -.060) in boys and no significant association with IQ scores among girls (B = 2.40; 95% CI -2.53 to 7.33). However, a 1-mg higher daily intake of fluoride among pregnant women was associated with a 3.66 lower IQ score (95% CI -7.16 to -0.14) for both boys and girls.
The authors believe that this study indicates that maternal exposure to higher levels of fluoride during pregnancy are associated with lower IQ scores in children aged 3 to 4. Ob/gyns treating patients in areas with fluoridated water may want to consult expectant mothers about reducing their fluoride intake during pregnancy, but given that these are new findings, more research is needed to clarify their significance.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Expert consensus sheds light on diagnosis and management of vasa previa
December 5th 2024A recent review established guidelines for prenatal diagnosis and care of vasa previa, outlining its definition, screening and diagnosis, management, and timing of delivery in asymptomatic patients.
Read More
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Reduced subsequent births reported after severe maternal morbidity
November 26th 2024Women experiencing severe maternal morbidity during their first pregnancy face significantly lower odds of subsequent births, emphasizing the need for personalized reproductive counseling and ongoing monitoring.
Read More